FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380577019> ?p ?o ?g. }

• W4380577019 abstract "Chronic venous insufficiency (CVI) is a condition related to chronic venous disease that may progress to venous leg ulceration and impair quality of life of those affected. Treatments such as physical exercise may be useful to reduce CVI symptoms. This is an update of an earlier Cochrane Review.To evaluate the benefits and harms of physical exercise programmes for the treatment of individuals with non-ulcerated CVI.The Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register, CENTRAL, MEDLINE, Embase, and CINAHL databases and World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov trials registers to 28 March 2022.We included randomised controlled trials (RCTs) comparing exercise programmes with no exercise in people with non-ulcerated CVI.We used standard Cochrane methods. Our primary outcomes were intensity of disease signs and symptoms, ejection fraction, venous refilling time, and incidence of venous leg ulcer. Our secondary outcomes were quality of life, exercise capacity, muscle strength, incidence of surgical intervention, and ankle joint mobility. We used GRADE to assess the certainty of the evidence for each outcome.We included five RCTs involving 146 participants. The studies compared a physical exercise group with a control group that did not perform a structured exercise programme. The exercise protocols differed between studies. We assessed three studies to be at an overall unclear risk of bias, one study at overall high risk of bias, and one study at overall low risk of bias. We were not able to combine data in meta-analysis as studies did not report all outcomes, and different methods were used to measure and report outcomes. Two studies reported intensity of CVI disease signs and symptoms using a validated scale. There was no clear difference in signs and symptoms between groups in baseline to six months after treatment (Venous Clinical Severity Score mean difference (MD) -0.38, 95% confidence interval (CI) -3.02 to 2.26; 28 participants, 1 study; very low-certainty evidence), and we are uncertain if exercise alters the intensity of signs and symptoms eight weeks after treatment (MD -4.07, 95% CI -6.53 to -1.61; 21 participants, 1 study; very low-certainty evidence). There was no clear difference in ejection fraction between groups from baseline to six months follow-up (MD 4.88, 95% CI -1.82 to 11.58; 28 participants, 1 study; very low-certainty evidence). Three studies reported on venous refilling time. We are uncertain if there is an improvement in venous refilling time between groups for baseline to six-month changes (MD 10.70 seconds, 95% CI 8.86 to 12.54; 23 participants, 1 study; very low-certainty evidence) or baseline to eight-week change (MD 9.15 seconds, 95% CI 5.53 to 12.77 for right side; MD 7.25 seconds, 95% CI 5.23 to 9.27 for left side; 21 participants, 1 study; very low-certainty evidence). There was no clear difference in venous refilling index for baseline to six-month changes (MD 0.57 mL/min, 95% CI -0.96 to 2.10; 28 participants, 1 study; very low-certainty evidence). No included studies reported the incidence of venous leg ulcers. One study reported health-related quality of life using validated instruments (Venous Insufficiency Epidemiological and Economic Study (VEINES) and 36-item Short Form Health Survey (SF-36), physical component score (PCS) and mental component score (MCS)). We are uncertain if exercise alters baseline to six-month changes in health-related quality of life between groups (VEINES-QOL: MD 4.60, 95% CI 0.78 to 8.42; SF-36 PCS: MD 5.40, 95% CI 0.63 to 10.17; SF-36 MCS: MD 0.40, 95% CI -3.85 to 4.65; 40 participants, 1 study; all very low-certainty evidence). Another study used the Chronic Venous Disease Quality of Life Questionnaire (CIVIQ-20), and we are uncertain if exercise alters baseline to eight-week changes in health-related quality of life between groups (MD 39.36, 95% CI 30.18 to 48.54; 21 participants, 1 study; very low-certainty evidence). One study reported no differences between groups without presenting data. There was no clear difference between groups in exercise capacity measured as time on treadmill (baseline to six-month changes) (MD -0.53 minutes, 95% CI -5.25 to 4.19; 35 participants, 1 study; very low-certainty evidence). We are uncertain if exercise improves exercise capacity as assessed by the 6-minute walking test (MD 77.74 metres, 95% CI 58.93 to 96.55; 21 participants, 1 study; very low-certainty evidence). Muscle strength was measured using dynamometry or using heel lifts counts. We are uncertain if exercise increases peak torque/body weight (120 revolutions per minute) (changes from baseline to six months MD 3.10 ft-lb, 95% CI 0.98 to 5.22; 29 participants, 1 study; very low-certainty evidence). There was no clear difference between groups in baseline to eight-week change in strength measured by a hand dynamometer (MD 12.24 lb, 95% CI -7.61 to 32.09 for the right side; MD 11.25, 95% CI -14.10 to 36.60 for the left side; 21 participants, 1 study; very low-certainty evidence). We are uncertain if there is an increase in heel lifts (n) (baseline to six-month changes) between groups (MD 7.70, 95% CI 0.94 to 14.46; 39 participants, 1 study; very low-certainty evidence). There was no clear difference between groups in ankle mobility measured during dynamometry (baseline to six-month change MD -1.40 degrees, 95% CI -4.77 to 1.97; 29 participants, 1 study; very low-certainty evidence). We are uncertain if exercise increases plantar flexion measured by a goniometer (baseline to eight-week change MD 12.13 degrees, 95% CI 8.28 to 15.98 for right leg; MD 10.95 degrees, 95% CI 7.93 to 13.97 for left leg; 21 participants, 1 study; very low-certainty evidence). In all cases, we downgraded the certainty of evidence due to risk of bias and imprecision.There is currently insufficient evidence to assess the benefits and harms of physical exercise in people with chronic venous disease. Future research into the effect of physical exercise should consider types of exercise protocols (intensity, frequency, and time), sample size, blinding, and homogeneity according to the severity of disease." @default.
• W4380577019 created "2023-06-15" @default.
• W4380577019 creator A5021336901 @default.
• W4380577019 creator A5032040993 @default.
• W4380577019 creator A5036950978 @default.
• W4380577019 creator A5045894190 @default.
• W4380577019 creator A5084491805 @default.
• W4380577019 creator A5090913970 @default.
• W4380577019 date "2023-06-14" @default.
• W4380577019 modified "2023-10-16" @default.
• W4380577019 title "Physical exercise for the treatment of non-ulcerated chronic venous insufficiency" @default.
• W4380577019 cites W1496722696 @default.
• W4380577019 cites W1536317173 @default.
• W4380577019 cites W187599507 @default.
• W4380577019 cites W1884856640 @default.
• W4380577019 cites W1965897438 @default.
• W4380577019 cites W1980819883 @default.
• W4380577019 cites W1981101553 @default.
• W4380577019 cites W1983845869 @default.
• W4380577019 cites W1984366284 @default.
• W4380577019 cites W1988914159 @default.
• W4380577019 cites W1991475780 @default.
• W4380577019 cites W1992585421 @default.
• W4380577019 cites W1995080680 @default.
• W4380577019 cites W2004659865 @default.
• W4380577019 cites W2010161780 @default.
• W4380577019 cites W2013499228 @default.
• W4380577019 cites W2043154694 @default.
• W4380577019 cites W2049103906 @default.
• W4380577019 cites W2077908502 @default.
• W4380577019 cites W2093721774 @default.
• W4380577019 cites W2096114903 @default.
• W4380577019 cites W2099404042 @default.
• W4380577019 cites W2106987732 @default.
• W4380577019 cites W2125435699 @default.
• W4380577019 cites W2134833483 @default.
• W4380577019 cites W2137481992 @default.
• W4380577019 cites W2137729136 @default.
• W4380577019 cites W2141797159 @default.
• W4380577019 cites W2156456070 @default.
• W4380577019 cites W2162426641 @default.
• W4380577019 cites W2163951953 @default.
• W4380577019 cites W2170025684 @default.
• W4380577019 cites W2170395820 @default.
• W4380577019 cites W2244323734 @default.
• W4380577019 cites W2291236127 @default.
• W4380577019 cites W2394958162 @default.
• W4380577019 cites W2400055742 @default.
• W4380577019 cites W2409246510 @default.
• W4380577019 cites W2467354016 @default.
• W4380577019 cites W2473091756 @default.
• W4380577019 cites W2559097597 @default.
• W4380577019 cites W2744038785 @default.
• W4380577019 cites W2791609264 @default.
• W4380577019 cites W2886343513 @default.
• W4380577019 cites W2894676926 @default.
• W4380577019 cites W2979692344 @default.
• W4380577019 cites W2997547953 @default.
• W4380577019 cites W3007080699 @default.
• W4380577019 cites W3028146046 @default.
• W4380577019 cites W3048503403 @default.
• W4380577019 cites W3095303702 @default.
• W4380577019 cites W3121044488 @default.
• W4380577019 cites W4210435822 @default.
• W4380577019 cites W4251900443 @default.
• W4380577019 cites W4252697995 @default.
• W4380577019 cites W4282822091 @default.
• W4380577019 cites W4285493257 @default.
• W4380577019 cites W4295715489 @default.
• W4380577019 cites W4297067663 @default.
• W4380577019 cites W80931259 @default.
• W4380577019 cites W90284254 @default.
• W4380577019 doi "https://doi.org/10.1002/14651858.cd010637.pub3" @default.
• W4380577019 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37314059" @default.
• W4380577019 hasPublicationYear "2023" @default.
• W4380577019 type Work @default.
• W4380577019 citedByCount "2" @default.
• W4380577019 countsByYear W43805770192023 @default.
• W4380577019 crossrefType "journal-article" @default.
• W4380577019 hasAuthorship W4380577019A5021336901 @default.
• W4380577019 hasAuthorship W4380577019A5032040993 @default.
• W4380577019 hasAuthorship W4380577019A5036950978 @default.
• W4380577019 hasAuthorship W4380577019A5045894190 @default.
• W4380577019 hasAuthorship W4380577019A5084491805 @default.
• W4380577019 hasAuthorship W4380577019A5090913970 @default.
• W4380577019 hasConcept C118552586 @default.
• W4380577019 hasConcept C126322002 @default.
• W4380577019 hasConcept C141071460 @default.
• W4380577019 hasConcept C159110408 @default.
• W4380577019 hasConcept C168563851 @default.
• W4380577019 hasConcept C17744445 @default.
• W4380577019 hasConcept C1862650 @default.
• W4380577019 hasConcept C199539241 @default.
• W4380577019 hasConcept C27415008 @default.
• W4380577019 hasConcept C2776106345 @default.
• W4380577019 hasConcept C2778640784 @default.
• W4380577019 hasConcept C2779473830 @default.
• W4380577019 hasConcept C2779951463 @default.
• W4380577019 hasConcept C2781145037 @default.
• W4380577019 hasConcept C71924100 @default.

• next